Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 24 peer-reviewed journal articles Updated
Oncology

Understanding Your Diagnosis and Identifying Emergency Signs

At a Glance

Solitary fibrous tumor is rare but often manageable when localized. Doege-Potter syndrome can cause dangerously low blood sugar, large tumors can compress the heart or lungs, and recurrence may occur years later, making specialist care and long-term follow-up important.

A diagnosis of Solitary Fibrous Tumor (SFT) can feel overwhelming, especially because most people—and many local doctors—have never heard of it. Understanding that this is an exceptionally rare condition is the first step in advocating for the specialized care you need. While SFT is a serious diagnosis that requires long-term attention, many patients have localized disease that can be successfully managed with expert treatment [1].

What is a Solitary Fibrous Tumor?

An SFT is a rare type of connective tissue tumor (a mesenchymal neoplasm) that can develop almost anywhere in the body [2][3]. While it most commonly arises in the pleura (the lining around the lungs), it is also found in the meninges (the lining of the brain), the abdomen, and various soft tissues [4][5].

These tumors are incredibly rare, with an estimated incidence of only 1 to 3.5 cases per million people each year [6][3]. To put that in perspective, SFTs account for less than 2% of all soft tissue tumors [2]. Because of this rarity, it is common for general practitioners to have little experience with the disease. Diagnosis often relies on modern pathology tools, specifically testing for the STAT6 protein or the NAB2-STAT6 gene fusion, which are the hallmarks of this condition [7][8].

Critical Emergency: Doege-Potter Syndrome

In rare cases, an SFT can cause a life-threatening metabolic emergency known as Doege-Potter Syndrome (DPS). This occurs when the tumor secretes a hormone called “Big” IGF-2, which mimics insulin and causes your blood sugar to drop to dangerously low levels (hypoglycemia) [9][10].

If you experience any of the following “red flag” symptoms, you must seek emergency medical care:

  • Severe confusion or unusual behavior [P-50]
  • Intense sweating and tremors [10]
  • Fainting or loss of consciousness (syncope) [11]
  • Seizures or entering a coma [12]

These symptoms often happen after fasting, such as first thing in the morning [10].

Emergency First-Aid Plan for DPS:
If you or a loved one experience these symptoms:

  1. If the person is awake and can swallow: Give 15–20 grams of fast-acting carbohydrates (like glucose tablets, fruit juice, or regular soda) exactly as directed by your clinical team. Test blood sugar and repeat if necessary.
  2. If the person is unconscious, confused, or seizing: Call emergency services (911) immediately. Do NOT give them food or drink by mouth, as they could choke. Place them safely on their side. Give prescribed glucagon only if a caregiver has been trained to do so. Tell the emergency dispatch and EMS that the patient has SFT and suspected Doege-Potter Syndrome.

In an emergency setting, the primary treatment is the immediate administration of intravenous dextrose (sugar) [11][13]. Removing the causative tumor, when feasible, is the preferred definitive treatment [14][15]. However, glucose support, corticosteroids, or other endocrine management may also be needed, and a cancer recurrence could bring the symptoms back.

Risks of Large (Giant) Tumors

When an SFT grows very large, particularly in the chest, it is often referred to as a giant SFT [16]. Depending on the tumor’s size and location, it may compress vital organs.

You should be alert for concrete signs that the tumor is putting pressure on your heart or lungs:

  • Severe or rapidly worsening shortness of breath, especially when lying flat [17]
  • Blue lips or face
  • Severe chest pain or a feeling of intense pressure [17]
  • Fainting or severe dizziness [18]

Giant tumors are often highly vascular, meaning they have a significant blood supply. This increases the risk of major bleeding during surgery [19][16]. For this reason, surgery for large SFTs requires a multidisciplinary team—including thoracic surgeons, specialized anesthesiologists, and sometimes interventional radiologists [15][20].

Your Outlook and Long-Term Care

For most patients, the primary treatment is complete surgical resection (removing the entire tumor) [1]. When the tumor is successfully removed, many of the associated symptoms, including the dangerous low blood sugar of Doege-Potter Syndrome, often resolve [5][21].

However, long-term follow-up is often advised because late recurrence has been reported. Even if a tumor is classified as low-risk, it can still recur or spread (metastasize) many years later [22]. Recurrences have been documented as late as 10 to 17 years after the initial surgery [22][23].

Because of this, an individualized, long-term follow-up plan is essential. If a tumor does return, it can sometimes trigger DPS symptoms again, making it vital to stay vigilant and maintain a relationship with a sarcoma specialist [24]. While the diagnosis is life-changing, being informed about these specific risks empowers you to seek the right help at the right time.

Common questions in this guide

Where can a solitary fibrous tumor develop?
A solitary fibrous tumor is a rare connective-tissue tumor that can arise almost anywhere in the body. It most often develops in the pleura, the lining around the lungs, but it can also occur in the meninges around the brain, the abdomen, or other soft tissues.
What does a STAT6 result tell me about an SFT diagnosis?
STAT6 protein expression in the tumor, or detection of the NAB2-STAT6 gene fusion, strongly supports a diagnosis of solitary fibrous tumor. The pathologist interprets these findings together with the tumor’s appearance and other tests.
How would I recognize Doege-Potter syndrome?
Doege-Potter syndrome is a rare complication in which an SFT causes dangerously low blood sugar. Warning signs can include intense sweating, tremors, confusion, unusual behavior, fainting, seizures, or loss of consciousness, often after fasting.
What should I do if someone with SFT is unconscious or having a seizure?
Call emergency services immediately and tell dispatch and EMS that the person has SFT and may have Doege-Potter syndrome. Do not give food or drink by mouth; place the person safely on their side, and give prescribed glucagon only if a trained caregiver has been instructed to do so.
Why might a giant SFT require a specialized surgical team?
A large SFT, especially in the chest, can press on the heart or lungs and may have a large blood supply that increases bleeding risk during surgery. Care may involve thoracic surgeons, specialized anesthesiologists, and sometimes interventional radiologists.
Can a solitary fibrous tumor return after surgery?
Yes. Even an SFT initially considered low risk can recur or spread many years after surgery, with some recurrences reported 10 to 17 years later. Your care team can create an individualized surveillance plan and may recommend ongoing follow-up with a sarcoma specialist.
How is low blood sugar from Doege-Potter syndrome treated?
Emergency treatment usually starts with intravenous dextrose to raise blood sugar quickly. Removing the tumor when feasible is the preferred definitive treatment, but glucose support, corticosteroids, or other hormone-related treatment may also be needed.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with Solitary Fibrous Tumors have you or this center treated in the last year?
  2. 2.Based on the size and location of my tumor, what is my risk for developing Doege-Potter Syndrome or heart and lung compression?
  3. 3.What specific instructions should I give my family or local emergency room if I become suddenly confused, sweaty, or faint?
  4. 4.Does my pathology report show STAT6 expression, and how does this confirm my diagnosis?
  5. 5.If my tumor is considered 'giant,' what specialized precautions will the surgical and anesthesia teams take to manage my blood pressure and airway during the procedure?
  6. 6.What is the long-term surveillance plan to monitor for a possible recurrence?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (24)
  1. 1

    Solitary fibrous tumor: molecular hallmarks and treatment for a rare sarcoma.

    Smrke A, Thway K, H Huang P, et al.

    Future oncology (London, England) 2021; (17(27)):3627-3636 doi:10.2217/fon-2021-0030.

    PMID: 34409859
  2. 2

    Solitary Fibrous Tumor of the Pleura: A Rare Cause of Pleural Mass.

    Supakul R, Sodhi A, Tamashiro CY, et al.

    The American journal of case reports 2015; (16()):854-7 doi:10.12659/ajcr.895289.

    PMID: 26632548
  3. 3

    A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.

    Martin-Broto J, Mondaza-Hernandez JL, Moura DS, Hindi N

    Cancers 2021; (13(12)) doi:10.3390/cancers13122913.

    PMID: 34200924
  4. 4

    Giant Solitary Fibrous Tumor of Pleura Presenting Both Benign and Malignant Features.

    Yagyu H, Hara Y, Murohashi K, et al.

    The American journal of case reports 2019; (20()):1755-1759 doi:10.12659/AJCR.919639.

    PMID: 31772146
  5. 5

    Giant Pleural Tumor And Severe Hypoglycemia: Doege-Potter Syndrome In A Previously Healthy Female.

    Junqueira N, Caldeira J, Ferreira R, et al.

    Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular 2020; (27(3)):223-226.

    PMID: 33068515
  6. 6

    Doege-Potter syndrome associated to metastatic solitary fibrous tumor.

    Andrade MO, de Sousa NDC, do Amaral PS, et al.

    Autopsy & case reports 2022; (12()):e2021412 doi:10.4322/acr.2021.412.

    PMID: 36569984
  7. 7

    The Current Status of Solitary Fibrous Tumor: Diagnostic Features, Variants, and Genetics.

    Thway K, Ng W, Noujaim J, et al.

    International journal of surgical pathology 2016; (24(4)):281-92 doi:10.1177/1066896915627485.

    PMID: 26811389
  8. 8

    Advances in the molecular biology of the solitary fibrous tumor and potential impact on clinical applications.

    Ren C, D'Amato G, Hornicek FJ, et al.

    Cancer metastasis reviews 2024; (43(4)):1337-1352 doi:10.1007/s10555-024-10204-8.

    PMID: 39120790
  9. 9

    Doege-Potter Syndrome: A Solitary Fibrous Tumor Causing Non-Islet Cell Tumor Hypoglycemia.

    Sheikh K, Mody A, Haynes AB, Kumar P

    JCEM case reports 2024; (2(2)):luae017 doi:10.1210/jcemcr/luae017.

    PMID: 38405103
  10. 10

    Doege-Potter syndrome due to a solitary fibrous tumor of the pleura: a case report.

    Estrada-Maya J, Montejo JS, Báez López KD, Garzón JC

    Journal of medical case reports 2024; (18(1)):383 doi:10.1186/s13256-024-04658-1.

    PMID: 39138498
  11. 11

    A Rare Diagnosis After the Fall of a 96-Year-Old Woman: Doege-Potter Syndrome.

    Pincelli AI, Perotti M, Massariello F, et al.

    Current aging science 2018; (11(3)):195-200 doi:10.2174/1874609812666181205142247.

    PMID: 30520387
  12. 12

    Doege-Potter Syndrome.

    Ahluwalia N, Attia R, Green A, et al.

    Annals of the Royal College of Surgeons of England 2015; (97(7)):e105-7 doi:10.1308/rcsann.2015.0023.

    PMID: 26414372
  13. 13

    Perioperative Continuous Glucose Monitoring During Resection of a Giant Intrathoracic Solitary Fibrous Tumour Associated With Doege-Potter Syndrome.

    Hayashi K, Kita Y, Nakamura R, Hanaoka J

    Interdisciplinary cardiovascular and thoracic surgery 2026; (41(5)) doi:10.1093/icvts/ivag132.

    PMID: 42105219
  14. 14

    Doege-Potter syndrome: A review of the literature including a new case report.

    Han G, Zhang Z, Shen X, et al.

    Medicine 2017; (96(27)):e7417 doi:10.1097/MD.0000000000007417.

    PMID: 28682900
  15. 15

    From Hypoglycaemia to Haemorrhage: A Case of Giant Pleural Solitary Fibrous Tumour With Doege-Potter Syndrome.

    Xie M, O'Donnabhain R, Cao Z, et al.

    Respirology case reports 2026; (14(1)):e70423 doi:10.1002/rcr2.70423.

    PMID: 41492398
  16. 16

    A rare case of Doege-Potter syndrome: Anesthesia considerations for the surgical removal of a benign solitary lung fibrous tumor.

    Indragandhi J, Krishnaprabu R

    Saudi journal of anaesthesia 2025; (19(3)):422-424 doi:10.4103/sja.sja_626_24.

    PMID: 40642653
  17. 17

    [Monstrous Solitary Fibrous Tumor of the Pleura - A Case Report and Review of the Literature].

    Prisadov G, Hendrix H, Kamlak V, Welcker K

    Pneumologie (Stuttgart, Germany) 2022; (76(1)):47-53 doi:10.1055/a-1542-7201.

    PMID: 34331296
  18. 18

    Pleural-based giant solitary fibrous tumour with associated hypoglycaemia: unusual presentation with pulmonary hypertension in a patient with Doege-Potter syndrome.

    Gohir Q, Ghosh S, Bosher O, et al.

    Clinical medicine (London, England) 2023; (23(5)):518-520.

    PMID: 37775170
  19. 19

    Case Report: Doege-Potter syndrome: a giant solitary fibrous pleural tumor causing severe hypoglycemia.

    De Vico C, Tappero C, Fontana E, et al.

    Frontiers in oncology 2025; (15()):1550343 doi:10.3389/fonc.2025.1550343.

    PMID: 40535137
  20. 20

    Recurrent Giant Solitary Fibrous Tumor.

    Barzanji N, Scott B, Shields M, et al.

    The Annals of thoracic surgery 2026; doi:10.1016/j.athoracsur.2026.04.028.

    PMID: 42067114
  21. 21

    Doege-Potter syndrome in a patient with solitary fibrous tumor of the pleura: a rare cause of refractory hypoglycemia-a case report.

    Laohathai S, Yu J, Dantis K, Tahir I

    AME case reports 2026; (10()):107 doi:10.21037/acr-2026-0007.

    PMID: 42299388
  22. 22

    Lessons Learned From an Untreated "Benign" Thoracic Tumor.

    Scrimgeour LA, Grada Z, Aswad BI, Ng T

    The Annals of thoracic surgery 2017; (103(2)):e135-e137 doi:10.1016/j.athoracsur.2016.07.006.

    PMID: 28109372
  23. 23

    Recurrence of solitary fibrous tumor of the pleura with hypoglycemia (Doege-Potter Syndrome): a case report description.

    Wang C, Cao T, Hu G, et al.

    Frontiers in oncology 2023; (13()):1245289 doi:10.3389/fonc.2023.1245289.

    PMID: 37823058
  24. 24

    Recurrence of a malignant solitary fibrous tumor of the pleura 17 years after primary tumor resection - A case report.

    Kovacs T, Waxman J

    Respiratory medicine case reports 2019; (28()):100895 doi:10.1016/j.rmcr.2019.100895.

    PMID: 31334027

This page is for informational purposes only and does not replace medical advice. If someone with SFT develops severe confusion, fainting, seizures, chest pain, or serious breathing problems, call emergency services and follow the clinical team’s instructions.

Get notified when new evidence is published on Solitary Fibrous Tumor (SFT).

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.